Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 149,593
  • Shares Outstanding, K 18,310
  • Annual Sales, $ 145,240 K
  • Annual Income, $ -76,420 K
  • EBIT $ -104 M
  • EBITDA $ -100 M
  • 60-Month Beta 0.21
  • Price/Sales 0.52
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 128.57% (+20.56%)
  • Historical Volatility 65.34%
  • IV Percentile 30%
  • IV Rank 10.19%
  • IV High 480.34% on 02/25/25
  • IV Low 88.67% on 12/11/25
  • Expected Move (DTE 7) 0.89 (10.28%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 650
  • Volume Avg (30-Day) 787
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 28,446
  • Open Int (30-Day) 26,010
  • Expected Range 7.79 to 9.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -2.26
  • Number of Estimates 3
  • High Estimate -1.66
  • Low Estimate -2.88
  • Prior Year -3.60
  • Growth Rate Est. (year over year) +37.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.99 +44.91%
on 12/17/25
8.95 -3.02%
on 01/09/26
+2.29 (+35.84%)
since 12/09/25
3-Month
5.01 +73.25%
on 11/07/25
8.95 -3.02%
on 01/09/26
+2.86 (+49.14%)
since 10/09/25
52-Week
3.51 +147.29%
on 04/01/25
11.40 -23.86%
on 01/10/25
-2.06 (-19.18%)
since 01/08/25

Most Recent Stories

More News
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass. , Jan. 2, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company...

KPTI : 8.68 (+6.24%)
Breakthrough ASH Data Drives Blood Cancer Market To $240B Valuation

Issued on behalf of GT Biopharma, Inc. VANCOUVER – Baystreet.ca News Commentary – The 2025 American Society of Hematology meeting showcased pivotal advances in blood cancer treatment, with...

PTGX : 80.22 (+0.02%)
KPTI : 8.68 (+6.24%)
GTBP : 0.6770 (-0.44%)
GSK : 50.39 (+0.34%)
TAK : 16.31 (-0.37%)
Karyopharm to Participate in Baird's Biotech Discovery Series

NEWTON, Mass. , Dec. 8, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's...

KPTI : 8.68 (+6.24%)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass. , Dec. 1, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company...

KPTI : 8.68 (+6.24%)
Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference

NEWTON, Mass. , Dec. 1, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's...

KPTI : 8.68 (+6.24%)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass. , Nov. 3, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company...

KPTI : 8.68 (+6.24%)
Karyopharm Therapeutics: Q3 Earnings Snapshot

Karyopharm Therapeutics: Q3 Earnings Snapshot

KPTI : 8.68 (+6.24%)
Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress

– Top-Line Data from the Phase 3 SENTRY Trial in Myelofibrosis on Track for March 2026 –

KPTI : 8.68 (+6.24%)
Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025

-- Conference Call Scheduled for Monday, November 3, 2025, at 8:00 a.m. ET --

KPTI : 8.68 (+6.24%)
Karyopharm Therapeutics Completes Financing Transactions for Growth

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Karyopharm...

KPTI : 8.68 (+6.24%)

Business Summary

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

See More

Key Turning Points

3rd Resistance Point 9.89
2nd Resistance Point 9.42
1st Resistance Point 9.05
Last Price 8.68
1st Support Level 8.21
2nd Support Level 7.74
3rd Support Level 7.37

See More

52-Week High 11.40
Last Price 8.68
Fibonacci 61.8% 8.39
Fibonacci 50% 7.45
Fibonacci 38.2% 6.52
52-Week Low 3.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar